查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555024

全球计算生物学市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Computational Biology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

全球计算生物学市场需求预计将从 2023 年的 63.6 亿美元达到近 203 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 13.76%。

计算生物学是一个跨学科领域，利用计算技术来理解和建模生物系统和过程。它涉及开发和应用演算法、数学模型和软体工具来分析复杂的生物资料，例如基因组序列、蛋白质结构和细胞相互作用。该领域对于解释大规模生物数据集、促进基因组学、蛋白质组学和系统生物学的进步至关重要。这有助于发现新的药物标靶、设计个人化医疗策略以及深入了解疾病的分子机制。将计算方法与生物学研究相结合，支持基础科学和应用科学的进步，推动药物发现、医学诊断和治疗开发的创新。

市场动态

基因组学和蛋白​​质组学研究产生的生物资料呈指数级增长，推动了计算生物学市场的发展，这需要复杂的计算工具来管理和分析这些资讯。个人化医疗和标靶治疗的日益普及推动了对预测患者特异性治疗反应的先进计算模型的需求。此外，人工智慧和机器学习的进步正在增强计算生物学工具的能力，从而可以更准确地预测和洞察复杂的生物系统。政府和私营部门对生物技术和医疗保健研究投资的增加进一步推动了市场成长。研究机构和技术公司之间的合作也促进了计算生物学应用的创新。此外，对高效药物发现和开发流程的需求为计算方法简化这些活动创造了机会，从而加快了医学进步的步伐。然而，先进计算工具的高成本以及整合不同生物资料的复杂性可能会阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球计算生物学市场的每个细分市场进行了包容性评估。计算生物学产业的成长和趋势为这项研究提供了整体方法。

市场区隔

计算生物学市场报告的这一部分提供了国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按服务

  • 资料库
  • 基础设施和硬体
  • 软体平台

按申请

  • 药物发现与疾病建模（标靶辨识、标靶验证、先导化合物发现、先导化合物优化）
  • 临床前药物开发（药物动力学、药效学）
  • 临床试验（一期、二期、三期、四期）
  • 计算基因组学
  • 计算蛋白质体学
  • 其他的

按最终用途

  • 学术与研究
  • 工业的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲计算生物学市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。计算生物学市场的主要参与者包括 DNAnexus、Illumina、Thermo Fisher Scientific、Schrodinger、Compugen、Aganitha AI Inc.、Genedata AG、Qiagen、Simulations Plus Inc. Fios Genomics。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：计算生物学 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按服务分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球计算生物市场分析：按服务分类

  • 按服务概览
  • 按服务进行历史和预测资料分析
  • 资料库
  • 基础设施和硬体
  • 软体平台

第 6 章：全球计算生物学市场分析：依应用分类

  • 概述：按应用
  • 历史与预测资料分析：按应用分类
  • 药物发现与疾病建模（标靶辨识、标靶验证、先导化合物发现、先导化合物优化）
  • 临床前药物开发（药物动力学、药效学）
  • 临床试验（一期、二期、三期、四期）
  • 计算基因组学
  • 计算蛋白质体学
  • 其他的

第 7 章：全球计算生物市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 学术与研究
  • 工业的

第 8 章：全球计算生物学市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：计算生物公司的竞争格局

  • 计算生物学市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • DNAnexus
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Illumina
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Schrodinger
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Compugen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Aganitha AI Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Genedata AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Qiagen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Simulations Plus Inc. Fios Genomics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112115581

The global demand for Computational Biology Market is presumed to reach the market size of nearly USD 20.3 Billion by 2032 from USD 6.36 Billion in 2023 with a CAGR of 13.76% under the study period 2024-2032.

Computational biology is an interdisciplinary field that utilizes computational techniques to understand and model biological systems and processes. It involves developing and applying algorithms, mathematical models, and software tools to analyze complex biological data, such as genomic sequences, protein structures, and cellular interactions. This field is essential for interpreting large-scale biological datasets, enabling genomics, proteomics, and systems biology advancements. This facilitates the discovery of new drug targets, the design of personalized medicine strategies, and the insight into the molecular mechanisms of diseases. Integrating computational methods with biological research supports the advancement of both basic and applied sciences, driving innovation in drug discovery, medical diagnostics, and therapeutic development.

MARKET DYNAMICS

The computational biology market is propelled by the exponential growth in biological data generated from genomics and proteomics research, which necessitates sophisticated computational tools to manage and analyze this information. The increasing adoption of personalized medicine & targeted therapies drives demand for advanced computational models that predict patient-specific treatment responses. Moreover, advancements in artificial intelligence & machine learning are enhancing the capabilities of computational biology tools, allowing for more accurate predictions & insights into complex biological systems. The rise in government and private sector investments in biotechnology and healthcare research further fuels market growth. Collaborations between research institutions and technology companies also foster innovation in computational biology applications. Additionally, the need for efficient drug discovery and development processes creates opportunities for computational approaches to streamline these activities, thereby accelerating the pace of medical advancements. However, the high cost of advanced computational tools and the complexity of integrating diverse biological data may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Computational Biology. The growth and trends of Computational Biology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Computational Biology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

  • Databases
  • Infrastructure & Hardware
  • Software Platform

By Application

  • Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization)
  • Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics)
  • Clinical Trial (Phase I, Phase II, Phase III, Phase IV)
  • Computational Genomics
  • Computational Proteomics
  • Others

By End-use

  • Academic & Research
  • Industrial

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Computational Biology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Computational Biology market include DNAnexus, Illumina, Thermo Fisher Scientific, Schrodinger, Compugen, Aganitha AI Inc., Genedata AG, Qiagen, Simulations Plus Inc. Fios Genomics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. COMPUTATIONAL BIOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY SERVICE

  • 5.1. Overview By Service
  • 5.2. Historical and Forecast Data Analysis By Service
  • 5.3. Databases Historic and Forecast Sales By Regions
  • 5.4. Infrastructure & Hardware Historic and Forecast Sales By Regions
  • 5.5. Software Platform Historic and Forecast Sales By Regions

6. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization) Historic and Forecast Sales By Regions
  • 6.4. Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics) Historic and Forecast Sales By Regions
  • 6.5. Clinical Trial (Phase I, Phase II, Phase III, Phase IV) Historic and Forecast Sales By Regions
  • 6.6. Computational Genomics Historic and Forecast Sales By Regions
  • 6.7. Computational Proteomics Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Academic & Research Historic and Forecast Sales By Regions
  • 7.4. Industrial Historic and Forecast Sales By Regions

8. GLOBAL COMPUTATIONAL BIOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE COMPUTATIONAL BIOLOGY COMPANIES

  • 9.1. Computational Biology Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF COMPUTATIONAL BIOLOGY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. DNAnexus
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Illumina
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Thermo Fisher Scientific
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Schrodinger
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Compugen
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Aganitha AI Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Genedata AG
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Qiagen
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Simulations Plus Inc. Fios Genomics
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Service (USD MN)
  • Databases Market Sales By Geography (USD MN)
  • Infrastructure & Hardware Market Sales By Geography (USD MN)
  • Software Platform Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization) Market Sales By Geography (USD MN)
  • Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics) Market Sales By Geography (USD MN)
  • Clinical Trial (Phase I, Phase II, Phase III, Phase IV) Market Sales By Geography (USD MN)
  • Computational Genomics Market Sales By Geography (USD MN)
  • Computational Proteomics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Academic & Research Market Sales By Geography (USD MN)
  • Industrial Market Sales By Geography (USD MN)
  • Global Computational Biology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Computational Biology Report
  • Market Research Process
  • Market Research Methodology
  • Global Computational Biology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Service
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Service (USD MN)
  • Databases Market Sales By Geography (USD MN)
  • Infrastructure & Hardware Market Sales By Geography (USD MN)
  • Software Platform Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Drug Discovery & Disease Modelling (Target Identification, Target Validation, Lead Discovery, Lead optimization) Market Sales By Geography (USD MN)
  • Preclinical Drug Development (Pharmacokinetics, Pharmacodynamics) Market Sales By Geography (USD MN)
  • Clinical Trial (Phase I, Phase II, Phase III, Phase IV) Market Sales By Geography (USD MN)
  • Computational Genomics Market Sales By Geography (USD MN)
  • Computational Proteomics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Academic & Research Market Sales By Geography (USD MN)
  • Industrial Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.